Immunotherapy: Cancer vaccine triggers antiviral-Type defences

Nature

Volumn 534, Issue 7607, 2016, Pages 329-331

  De Vries, Jolanda ^a   Figdor, Carl ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIGEN; CANCER VACCINE; NANOPARTICLE; TUMOR ANTIGEN; RNA; VIRUS ANTIGEN;

CANCER; DEFENSE MECHANISM; DISEASE TREATMENT; IMMUNE SYSTEM; VACCINE; VIRAL DISEASE;

ARTICLE; AUTHOR; CANCER CELL; DEFENSE MECHANISM; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOTHERAPY; INFECTION; MONOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; VACCINATION; ANIMAL; FEMALE; IMMUNOLOGY; MALE; MELANOMA; METABOLISM; PROCEDURES;

ANIMALS; ANTIGENS, NEOPLASM; ANTIGENS, VIRAL; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNOTHERAPY; MALE; MELANOMA; RNA;

EID: 84976623109     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature18443     Document Type: Article

References (11)

1. Kranz, L. M. et al. Nature 534, 396-401 (2016).
2. Joyce, J. A. & Fearon, D. T. Science 348, 74-80 (2015).
3. Palucka, K. & Banchereau, J. Nature Rev. Cancer 12, 265-277 (2012).
4. Tel, J. et al. Cancer Res. 73, 1063-1075 (2013).
5. Tacken, P. J., de Vries, I. J., Torensma, R. & Figdor, C. G. Nature Rev. Immunol. 7, 790-802 (2007).
6. Bonifaz, L. C. et al. J. Exp. Med. 196, 1627-1638 (2002).
7. Bonifaz, L. C. et al. J. Exp. Med. 199, 815-824 (2004).
8. Tacken, P. J. et al. Blood 106, 1278-1285 (2005).
9. Cruz, L. J. et al. J. Control. Release 144, 118-126 (2010).
10. https://clinicaltrials.gov/ct2/results?term=dec-205&Search=Search
11. Kuhn, A. N. et al. Gene Ther. 17, 961-971 (2010).